SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-15-369203
Filing Date
2015-11-06
Accepted
2015-11-06 07:43:06
Documents
4
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d26484d10qa.htm 10-Q/A 39665
2 EX-10.10 d26484dex1010.htm EX-10.10 173184
3 EX-10.11 d26484dex1011.htm EX-10.11 45456
4 GRAPHIC g26484g43o02.jpg GRAPHIC 18051
  Complete submission text file 0001193125-15-369203.txt   284450
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35238 | Film No.: 151202446
SIC: 2834 Pharmaceutical Preparations